Amo Pharma Limited
Clinical trials sponsored by Amo Pharma Limited, explained in plain language.
-
Drug tested to ease debilitating muscle disease in young people
Disease control CompletedThis study tested whether a drug called Tideglusib is safe and helpful for adolescents and adults with a severe, early-onset form of myotonic dystrophy, a genetic muscle-wasting disease. Sixteen participants aged 12-45 received the drug to see if it could improve muscle function,…
Phase: PHASE2 • Sponsor: AMO Pharma Limited • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Hope for kids with rare muscle disease in drug trial
Disease control CompletedThis study tested whether a drug called tideglusib could help children and teenagers (ages 6-16) with congenital myotonic dystrophy, a rare genetic muscle disease. Researchers compared tideglusib to a placebo (inactive pill) to see if it could improve symptoms, daily function, an…
Phase: PHASE2, PHASE3 • Sponsor: AMO Pharma Limited • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC